Search
Search Constraints
You searched for: ISSN 0049-3848Limit your search
- Journal Article4,200
- Thrombosis research4,200
- , 167
- Carrier, Marc 51
- Prandoni, Paolo 41
- Monreal, Manuel 38
- Rodger, Marc 36
- Ageno, Walter 29
- Hvas, Anne-Mette 27
- Klok, Frederikus A. 27
- Barco, Stefano 26
- Kirwan, C.C. 26
- 616.135 4,200
- Thrombosis -- Periodicals 4,200
- Bridging -- Anticoagulation -- Peri-procedural -- Interruption -- Warfarin -- Paediatric -- Clinical outcomes -- Moyamoya 3
- A/C oral anticoagulants -- APC activated protein C -- BMI Body Mass Index -- CRP C-reactive protein -- DVT deep vein thrombosis -- EDTA ethylenediaminetetraacetic acid -- ELISA enzyme-linked immunosorbent assay -- FXIII Factor XIII -- HI healthy individuals -- IQR interquartile range -- n/a not applicable -- proTAFI pro thrombin activatable fibrinolysis inhibitor -- PTS post thrombotic syndrome -- TAT thrombin-antithrombin complex -- TMB 3, 3′, 5, 5′-tetramethylbenzidine -- tPA tissue plasminogen activator -- VTE venous thromboembolism 2
- AC anticoagulation -- APS antiphospholipid antibody syndrome -- CIs confidence intervals -- CVRN VTE Cardiovascular Research Network Venous Thromboembolism -- DVT deep vein thrombosis -- ICD-9 International Classification of Diseases 9th Revision -- Ig immunoglobulin -- KPCO Kaiser Permanente Colorado -- NPV(s) negative predictive value(s) -- PE pulmonary embolism -- PPV(s) positive predictive value(s) -- RIETE Registro Informatizado de Enfermedad TromboEmbolica -- VTE venous thromboembolism 2
- ACCP American College of Chest Physicians -- ASA acetylsalicylic acid -- bid twice daily -- BMI body mass index -- CI confidence interval -- CrCl creatinine clearance -- DVT deep vein thrombosis -- ESC European Society of Cardiology -- ISTH International Society on Thrombosis and Haemostasis -- LMWH low molecular weight heparin -- NICE National Institute for Health and Care Excellence -- NOAC non-vitamin K antagonist oral anticoagulant -- NR not reported -- OAC oral anticoagulant -- od once daily -- OR odds ratio -- PE pulmonary embolism -- RRR relative risk reduction -- UFH unfractionated heparin -- VKA vitamin K antagonist -- VTE venous thromboembolism 2
- ACE angiotensin converting enzyme -- ALDO aldosterone -- Ang II angiotensin II -- AT1 angiotensin II receptor type 1 -- AT2 angiotensin II receptor type 2 -- APTT activated partial thromboplastin time -- BT bleeding time -- CBF carotid blood flow -- DBP diastolic blood pressure -- EGFR epidermal growth factor receptor -- EPL eplerenone -- F + P fibrin mixed with platelet aggregates -- GPR30 G protein-coupled receptor for estrogen -- GR glucocorticoid receptor -- HCMAs human coronary microarteries -- HCT hematocrit -- HGB hemoglobin -- HR heart rate -- HUVECs Human Umbilical Vein Endothelial Cells -- MR mineralocorticoid receptor -- NO nitric oxide -- NO2− nitrite -- NO3− nitrate -- NOS nitric oxide synthase -- PAI-1 plasminogen activator inhibitor type 1 -- PLT platelets -- PRP platelet rich plasma -- PT prothrombin time -- RAAS rennin–angiotensin–aldosterone system -- RBCs red blood cells -- SBP systolic blood pressure -- TAFI thrombin activatable fibrinolysis inhibitor -- t-PA tissue plasminogen activator -- TT thrombin time -- VAL valsartan -- VEH vehicle -- VSMCs vascular smooth muscle cells -- WBCs white blood cells 2
- ACTB beta-actin -- BMI body mass index -- DVT deep venous thrombosis -- HI healthy individuals -- IL-6 interleukin-6 -- IL-8 interleukin-6 -- IQR interquartile range -- RT residual thrombosis -- SDHA succinate dehydrogenase subunit A -- TLR9 toll-like receptor 9 -- Th1 T-lymphocyte helper 1 2
- ADAMTS-13 a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 -- DTT dithiothreitol -- ECM extracellular matrix -- ELISA enzyme linked immunosorbent assay -- FVIII coagulation factor VIII -- GOF gain-of-function -- GPIb glycoprotein Ib -- HRP horseradish peroxidase -- MALDI-TOF-MS matrix-assisted laser desorption ionization-time of flight mass spectrometry -- MMA multimer analysis -- MPB biotin-linked maleimide -- MS mass spectrometry -- NEM N-ethylmaleimide -- NTA nitrilotriacetic acid -- RBCs red blood cells -- PBS phosphate buffered saline -- PDI protein disulfide-isomerase -- RT room temperature -- RU response units -- SPR surface plasmon resonance -- ULVWF ultralarge VWF (multimers) -- VWF von Willebrand factor -- VWF:Ag von Willebrand factor antigen 2
- AE adverse event -- aPTT activated partial thromboplastin time -- CrCl creatinine clearance -- CV coefficient of variation -- dTT diluted thrombin time (Hemoclot® Thrombin Inhibitors) -- ECT ecarin clotting time -- HPLC-MS/MS high-performance liquid chromatography tandem mass spectrometry -- PPS per-protocol set -- qd once daily -- THR total hip replacement -- TKR total knee replacement -- VTE venous thromboembolism 2